Description |
Product Type |
Product Size |
Injection
|
1'S |
Product Company |
GP Pharm |
Leuprorelin Acetate 22.5mg
|
Product Type |
Product Size |
Capsules |
100'S |
Product Company |
Pharmedic |
Hydroxyurea 500mg |
Product Type |
Product Size |
Injection |
1'S |
Product Company |
Helix pharma |
Methotrexate 50mg/2ml
|
Product Type |
Product Size |
injection |
1'S |
Product Company |
Pharmedic |
Dacarbazine 200mg |
Product Type |
Product Size |
Injection |
1'S |
Product Company |
Oncovanz |
Bleomycin 15U |
Product Type |
Product Size |
Tablet |
30'S |
Product Company |
Manufacture Deva Holding / Marketed by Searle |
Letrozole 2.5mg |
Content | Leuprolide is a peptide-based GnRH receptor superagonist used for the palliative treatment of prostate cancer, uterine leiomyomata, endometriosis, and central precocious puberty."
| Hydroxyurea is in a class of medications called antimetabolites. Hydroxyurea treats cancer by slowing or stopping the growth of cancer cells in your body. Hydroxyurea treats sickle cell anemia by helping to prevent formation of sickle-shaped red blood cells. | Methotrexate is an antineoplastic agent used the treatment of a wide variety of cancers as well as severe psoriasis, severe rheumatoid arthritis, and juvenile rheumatoid arthritis.
| Dacarbazine, also known as imidazole carboxamide, is a chemotherapy medication used in the treatment of melanoma and Hodgkin's lymphoma. For Hodgkin's it is often used together with vinblastine, bleomycin, and doxorubicin. | Bleomycin has approval for adult use in treating squamous cell cancer of head and neck regions, Hodgkin's lymphoma, testicular carcinoma. It is also used as a sclerosing agent for malignant pleural effusions. | Letrozole is a non-steroidal type II aromatase inhibitor. It blocks the active site, and therefore the electron transfer chain of CYP19A1. This competitive inhibition prevents the conversion of androgens to estrogen. This action leads to a reduction in uterine weight and elevated leuteinizing hormon. |
Reviews
There are no reviews yet.